Original-Research: Rubean AG - von NuWays AG
Einstufung von NuWays AG zu Rubean AG
Unternehmen: Rubean AG
ISIN: DE0005120802
Anlass der Studie: Update
Empfehlung: BUY
seit: 09.01.2024
Kursziel: 8.00
Kursziel auf Sicht von: 12 Monaten
Letzte Ratingänderung:
Analyst: Frederik Jarchow
FY23 sales in line with estimates // POS rollout has started; chg
Topic: Yesterday, Rubean announced to have reached more than € 1.0m in sales (prelims) and quadrupled number of app users to c. 25k vs 6k at the end of 2022 (eNuW).
With > € 1.0m, Rubean increased sales by >20% yoy, which is slightly better than expected (eNuW old: € 0.98m; 17% yoy). Still, we consider 2023 as a transition year that was characterized by a delayed product roll-out resulting in a negative EBIT to the tune of € 3.6m (eNuW).
Positively, the recently announced new partnerships with i.e. Correos in Spain and emerchantpay as well as the quadrupling of app users is seen to bode well for Rubean and should start to materialize this year. Importantly, with Correos (12k devices already in use, further 15k should follow this month), Rubean is not only earning a monthly license fee per user, but is also participating in every transaction, executed via the software. Indeed, we consider this highly profitable revenue sharing scheme as a blueprint for future partnerships.
As Rubean´s leading softPOS product is ready for rollout, further new customer wins and partnerships are clearly in the cards for this year allowing for a continued dynamic top-line development. As Rubean should already be in advanced discussions with several potential partners, we expect positive newsflow from several new partnerships within the next couple of weeks and months that should further ramp-up sales and EBIT going forward.
In detail, we expect sales of € 2.9m and an EBIT of € -1.6m for FY24e. Mind you, that these estimates can be seen as rather conservative, as we have only considered growing sales with already signed customers.
Thanks to the SaaS model, scalability should kick-in quickly. Operating break-even should be hence reached already within next year. As said, considering a high likelihood of additional customer-wins, the break-even could be achieved even earlier.
In order to reflect the ramp-up potential stemming from the product roll-out and new partnerships, we reiterate BUY with an unchanged PT of € 8.00, based on our DCF.
Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/28621.pdf
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.
Kontakt für Rückfragen
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.
Kontakt für Rückfragen
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++
-------------------übermittelt durch die EQS Group AG.-------------------
Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.